Bio/Pharmaceutical GMP Product Testing
Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world?s largest pharmaceutical, biopharmaceutical and medical device companies.
Bio/Pharmaceutical GMP Product Testing
Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world’s largest pharmaceutical, biopharmaceutical and medical device companies.
Our service offerings are fully comprehensive and include testing of drug substance, final product, intermediates, and starting materials for both small and large molecule drug products.
With a global capacity of more than 500,000 square feet and facilities located in Belgium, Denmark, France, Germany, Ireland, Italy, Spain, Sweden and the U.S., our network of GMP laboratories operates under the same strict quality procedures, LIMS and centralized billing system across 14 locations worldwide.
We give our clients the flexibility to choose from five service models to meet specific project needs, including the award-winning Professional Scientific StaffingSM (PSS) and we also provide secure 24-hour data access via our online data portal, LabAccess.com SM.
Company name: Eurofins Scientific
Website: www.Eurofins.com/Biopharma
E-mail:
Pharma@Eurofins.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
